BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16597584)

  • 1. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
    Campo K; De Staebel O; Gijsbrechts E; van Waterschoot W
    Health Mark Q; 2005; 22(4):73-107. PubMed ID: 16597584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design.
    Hailu AD; Workneh BD; Kahissay MH
    BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of physicians' participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany.
    Koch C; Schleeff J; Techen F; Wollschläger D; Schott G; Kölbel R; Lieb K
    PLoS Med; 2020 Jun; 17(6):e1003151. PubMed ID: 32589633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug samples--does this marketing strategy counteract policies for quality use of medicines?
    Groves KE; Sketris I; Tett SE
    J Clin Pharm Ther; 2003 Aug; 28(4):259-71. PubMed ID: 12911677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pharmaceutical marketing and other factors in prescribing decisions: the Yemeni experience.
    Al-Areefi MA; Hassali MA; Mohamed Ibrahim MI
    Res Social Adm Pharm; 2013; 9(6):981-8. PubMed ID: 23218551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
    Oldani MJ
    Med Anthropol Q; 2004 Sep; 18(3):325-56. PubMed ID: 15484967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of e-detailing on the number of new prescriptions.
    Gönül FF; Carter FJ
    Health Care Manag Sci; 2010 Jun; 13(2):101-11. PubMed ID: 20629413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription tracking and public health.
    Fugh-Berman A
    J Gen Intern Med; 2008 Aug; 23(8):1277-80. PubMed ID: 18473146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pharmaceutical companies' marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study.
    Al Thabbah DH; Almahairah MS; Naser AY; Alrawashdeh HM; Araidah M
    BMC Health Serv Res; 2022 Oct; 22(1):1293. PubMed ID: 36303214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of marketing in pharmaceutical research and development.
    Calfee JE
    Pharmacoeconomics; 2002; 20 Suppl 3():77-85. PubMed ID: 12457428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
    Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
    BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors.
    Naik AD; Woofter AL; Skinner JM; Abraham NS
    Am J Manag Care; 2009 Apr; 15(4):e9-15. PubMed ID: 19341315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do drug costs affect physicians' prescription decisions?
    Hart J; Salman H; Bergman M; Neuman V; Rudniki C; Gilenberg D; Matalon A; Djaldetti M
    J Intern Med; 1997 May; 241(5):415-20. PubMed ID: 9183310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
    Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
    BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making.
    Chinburapa V; Larson LN; Brucks M; Draugalis J; Bootman JL; Puto CP
    Soc Sci Med; 1993 Jun; 36(11):1473-82. PubMed ID: 8511635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.